Pioglitazone and Lung disorder - a phase IV clinical study of FDA data

Summary:

Lung disorder is reported as a side effect among people who take Pioglitazone (pioglitazone hydrochloride), especially for people who are female, 60+ old, also take Vitamin D2, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Lung disorder when taking Pioglitazone. It is created by eHealthMe based on reports of 12,725 people who have side effects when taking Pioglitazone from the FDA, and is updated regularly.

What is Pioglitazone?

Pioglitazone has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 12,864 Pioglitazone users. Check the latest studies of Pioglitazone.

What is Lung disorder?

Lung disorder (lung disease) is found to be associated with 1,803 drugs and 1,787 conditions by eHealthMe. Check the latest studies of Lung disorder.

On Jul, 26, 2026

12,725 people reported to have side effects when taking Pioglitazone.
Among them, 28 people (0.22%) have Lung disorder.

Among these 28 people:

What is the gender of people who have Lung disorder when taking Pioglitazone? *

female: 57.69 %
male: 42.31 %

What is the age of people who have Lung disorder when taking Pioglitazone? *

What are other drugs people take besides Pioglitazone? *

What are other side effects people have besides Lung disorder? *

Sleep Disorder: 8 people, 28.57%
Oxygen Saturation Decreased: 7 people, 25.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 25.00%
Rashes (redness): 6 people, 21.43%
Dyspnea (difficult or laboured breathing): 6 people, 21.43%
Blood Pressure Abnormal: 5 people, 17.86%
Death: 5 people, 17.86%
Heart Rate Decreased: 4 people, 14.29%
Oral Candidiasis (fungal infection of mouth): 4 people, 14.29%
Fatigue (feeling of tiredness): 4 people, 14.29%

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 14.29%
Rashes (redness): 4 people, 14.29%
Primary Immunodeficiency Syndrome: 4 people, 14.29%
Immunodeficiency Common Variable: 4 people, 14.29%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 10.71%
Asthma: 3 people, 10.71%
Hyperkalemia (damage to or disease of the kidney): 3 people, 10.71%
Premenstrual Syndrome: 2 people, 7.14%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 2 people, 7.14%
Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Pioglitazone and have Lung disorder?

- Check whether Lung disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pioglitazone:

Pioglitazone (12,864 reports)

Lung disorder treatments and more:

Lung disorder (66,567 reports)

Browse all side effects of Pioglitazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lung disorder:

Lung disorder (1,803 drugs)

Browse all the conditions that are associated with Lung disorder:

Lung disorder (1,787 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pioglitazone hydrochloride (the active ingredients of Pioglitazone) and Pioglitazone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.